7‐Nitro‐1H‐indazole,an inhibitor of nitric oxide synthase

The crystal structure of 7‐nitro‐1H‐indazole, C₇H₅N₃O₂, an inhibitor of nitric oxide synthase, shows the existence of an intramolecular hydrogen bond between an O atom of the nitro group and the NH group of the indazole ring. The crystal packing consists of intermolecular hydrogen bonding and indazole?indazole interactions.     

7‐Nitro­indazole

The title compound, C₇H₅N₃O₂, is an inhibitor of nitric oxide synthase and mono­amine oxidase. The N1H tautomer crystallized as a dimer and adopts a planar conformation assisted by intramolecular hydrogen bonding.     

1H‐Indazole and 2H‐indazole derivatives of androsta‐5,16‐dien‐3β‐ol

The title compounds, 17‐(1H‐indazol‐1‐yl)androsta‐5,16‐dien‐3β‐ol, (I), and 17‐(2H‐indazol‐2‐yl)androsta‐5,16‐dien‐3β‐ol, (II), both C₂₆H₃₂N₂O, have an indazole substituent at the C17 position. The six‐membered B ring of each compound assumes a half‐chair conformation. A twist of the steroid skeleton is observed and reproduced in quantum‐mechanical ab initio calculations of the isolated molecule using a molecular orbital Hartree–Fock method. In the 1H‐indazole derivative, (I), the molecules are joined in a head‐to‐head fashion via O—H...O hydrogen bonds, forming chains along the a axis. In the 2H‐indazole derivative, (II), the molecules are joined in a head‐to‐tail fashion with one of the N atoms of the indazole ring system acting as the acceptor. The hydrogen‐bond pattern consists of zigzag chains running along the b axis. Substituted steroids have proven to be effective in inhibiting androgen biosynthesis through coordination of the Fe atoms of some enzymes, and this study shows that indazole‐substituted steroids adopt twisted conformations that restrict their intermolecular interactions.     

Polymorphism vs. Desmotropy: The Cases of 3‐Phenyl‐ and 5‐Phenyl‐ 1H‐pyrazoles and 3‐Phenyl‐1H‐indazole

Two desmotropes, 3‐phenyl‐1H‐pyrazole ( 1a ) and 5‐phenyl‐1H‐pyrazole ( 1b ) have been isolated and the conditions for their interconversion established. The X‐ray structure of 1b has been determined (a=10.862(1), b=5.7620(5), c=12.927(2) Å, β=111.435(2)°, space group P2₁/c), and both tautomers 1a and 1b were characterized by NMR in the solid state (¹³C‐ and ¹⁵N‐CPMAS). In the case of 3‐phenyl‐1H‐indazole ( 2a ), two concomitant polymorphs have been analyzed by X‐ray crystallography, and their NMR spectral properties were determined. The low‐melting‐point polymorph, at 106.7°, contains three molecules in the asymmetric unit (a=41.086(1), b=7.3860(2), c=23.391(1) Å, β=117.697(1)°, space group C2/c) and the high‐melting‐point one, 115.3°, six molecules (a=13.7818(4), b=13.7976(5), c=18.9445(5) Å, α=94.300(3), β=95.131(3), γ=119.428(3)°, space group P‐1). Here, too, it has been experimentally determined how to transform one form into the other. Density‐functional‐theory calculations at the B3LYP/6‐31G** level have been performed in both examples to rationalize the stability of the different tautomers.     

Synthesis and Characterization of Novel 1‐Methyl‐3‐(4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazole Derivatives

A series of novel 1‐methyl‐3‐(4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles was synthesized in three steps from 5‐(1‐methyl‐1H‐indazol‐3‐yl)‐4‐phenyl‐2H‐1,2,4‐triazole‐3(4H)‐thiones. 5‐(1‐Methyl‐1H‐indazol‐3‐yl)‐4‐phenyl‐2H‐1,2,4‐triazole‐3(4H)‐thiones were converted into 1‐methyl‐3‐(5‐(methylsulfonyl)‐4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles upon methylation followed by treatment with aq. KMnO₄. The reaction of 1‐methyl‐3‐(5‐(methylsulfonyl)‐4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles with Raney nickel resulted in desulphonylation to afford corresponding 1‐methyl‐3‐(4‐phenyl‐4H‐1,2,4‐triazol‐3‐yl)‐1H‐indazoles. All the new synthesized compounds were characterized by spectral techniques.     

Regiospecific synthesis of 5‐(1H‐indol‐2‐yl)‐1‐ and 2‐methyl‐6,7‐dihydro‐2H‐indazole isomers

A regiospecific approach to each N‐methyl‐5‐(1H‐indol‐2‐yl)‐6,7‐dihydro‐2H‐indazole isomer is reported. The 1‐methyl isomer 1 was prepared from 5‐bromo‐1‐methyl‐6,7‐dihydro‐1H‐indazole 3 and indole‐2‐boronate 5 by palladium catalyzed Suzuki coupling. The 2‐methyl regioisomer 2 was synthesized via addition of lithium (1‐carboxylato‐1H‐indole‐2‐yl)lithium 6 with 2‐methyl‐2,4,6,7‐tetrahydro‐indazol‐5‐one 8 followed by acid catalyzed dehydration.     

4‐Phenyl‐1H‐imidazole (a low‐temperature redetermination), 1‐benzyl‐1H‐imidazole and 1‐mesityl‐1H‐imidazole

Low‐temperature studies of the simple variously substituted imidazole types 4‐phenyl‐1H‐imidazole, C₉H₈N₂, 1‐benzyl‐1H‐imidazole, C₁₀H₁₀N₂, and 1‐mesityl‐1H‐imidazole, C₁₂H₁₄N₂, extend comparisons between parent imidazole species and their derivatives, the pronounced double‐bond localization opposite the substituted N atom common to simple neutral species being redistributed aromatically on protonation.     

7‐Methoxy‐3‐(salicyl­idene­amino)­coumarin

The title compound, C₁₇H₁₃NO₄, exists as a planar mol­ecule; adjacent mol­ecules are linked by electrostatic C—H?O [C?O = 3.318 (4) and 3.455 (4) Å] interactions into a linear chain.     

7‐Methoxy‐2,3‐dioxo‐1,4‐dihydroquinoxalin‐6‐aminium chloride monohydrate

Single crystals of the title compound, C₉H₁₀N₃O₃⁺·Cl⁻·H₂O, were obtained by recrystallization from hydrochloric acid. The cations stack along the crystallographic a direction. The 2,3‐dioxo‐1,4‐dihydroquinoxaline group shows a significant deviation from planarity [r.m.s. deviation from the best plane = 0.063 (2) Å]. Hydrogen bonding links the cations, chloride anions and water molecules to form an extended three‐dimensional architecture.     

1‐(2‐Deoxy‐β‐d‐erythro‐pento­furan­osyl)‐4‐nitro‐1H‐indazole

In the title compound, C₁₂H₁₃N₃O₅, the conformation of the gly­cosyl­ic bond is anti [torsion angle = −105.3 (2)°]. The 2′‐deoxy­ribo­furan­ose moiety adopts an S‐type sugar pucker and the orientation of the exocyclic C—C bond is −sc (trans).     

7‐Hydr­oxy‐6‐methoxy‐3‐[(2‐oxo‐2H‐1‐benzopyran‐7‐yl)oxy]‐2H‐1‐benzopyran‐2‐one

The title compound, daphnoretin, C₁₉H₁₂O₇, was isolated from the leaves of Stellera chamaejasme L. Two independent mol­ecules are present in the asymmetric unit, with similar conformations. Each of the independent mol­ecules is composed of two chromene systems connected by an ether bridge. The dihedral angles between the mean planes of the two chromene systems are 86.9 (2) and 81.9 (3)°. Mol­ecules form chains via hydrogen bonds and adjacent chains are parallel to each other.     

1H,1′H‐2,2′‐Bibenz­imidazole

In the title compound, C₁₄H₁₀N₄, all the atoms are close to being coplanar (r.m.s. deviation 0.0098 Å) except for the imino H atoms. The mol­ecule forms a one‐dimensional chain through intermolecular N—H?N hydrogen bonds.     

A new one‐dimensional CuII complex with a three‐dimensional supramolecular architecture incorporating benzene‐1,3‐dicarboxylate and 1‐[(1H‐benzotriazol‐1‐yl)methyl]‐1H‐imidazole

Subtle modifications of N‐donor ligands can result in complexes with very different compositions and architectures. In the complex catena‐poly[[bis{1‐[(1H‐benzotriazol‐1‐yl)methyl]‐1H‐imidazole‐κN ³}copper(II)]‐μ‐benzene‐1,3‐dicarboxylato‐κ³O ¹,O ^1′:O ³], {[Cu(C₈H₄O₄)(C₁₀H₉N₅)₂(H₂O)]·2H₂O}_n , each Cu^II ion is six‐coordinated by two N atoms from two crystallographically independent 1‐[(1H‐benzotriazol‐1‐yl)methyl]‐1H‐imidazole (bmi) ligands, by three O atoms from two symmetry‐related benzene‐1,3‐dicarboxylate (bdic²⁻) ligands and by one water molecule, leading to a distorted CuN₂O₄ octahedral coordination environment. The Cu^II ions are connected by bridging bdic²⁻ anions to generate a one‐dimensional chain. The bmi ligands coordinate to the Cu^II ions in monodentate modes and are pendant on opposite sides of the main chain. In the crystal, the chains are linked by O—H…O and O—H…N hydrogen bonds, as well as by π–π interactions, into a three‐dimensional network. A thermogravimetric analysis was carried out and the fluorescence behaviour of the complex was also investigated.     

Novel Bisphosphonates Derived from 1H‐Indazole, 1H‐Pyrazolo[3,4‐b]Pyridine,and 1H‐Pyrazolo[3,4‐b]Quinoline

Novel tetraethyl ethylene‐1,1‐bisphosphonate esters derived from 1H‐indazole, 1H‐pyrazolo[3,4‐b]pyridine, and 1H‐pyrazolo[3,4‐b]quinoline were synthesized by a Michael addition reaction of tetraethyl ethylidene‐1,1‐bisphosphonate with the corresponding heterocycle, using conventional heating and microwave‐assisted methods. The microwave‐assisted method provides shorter reaction times and better yields. The hydrolysis of bisphosphonates afforded the corresponding bisphosphonic acids or salt, using concentrated hydrochloric acid or TMSBr/collidine, respectively. All new compounds were fully characterized, and their structures were assigned using ¹H, ³¹P, and ¹³C NMR and IR spectroscopies and mass spectrometry. The molecular structure of compound 6 was confirmed by X‐ray diffraction studies.     

Synthesis of some new 1‐acyl‐5‐aryl‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐4,5‐dihydro‐1H‐pyrazole

Some new compounds (E)‐3‐aryl‐1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐prop‐2‐en‐1‐ones 5a–e were prepared by 1‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐ethanone and various aromatic aldehydes. Then one pot reaction was happened by compounds 5a–e with hydrazine hydrate in acetic acid or propionic acid, respectively, to give the title compounds 1acyl‐5‐aryl‐3‐(5‐methyl‐1‐p‐tolyl‐1H‐1,2,3‐triazol‐4‐yl)‐4,5‐dihydro‐1H‐pyrazoles 6a–i . All structures were established by MS, IR, CHN, ¹H‐NMR and ¹³C‐NMR spectral data. J. Heterocyclic Chem., (2012).     

Thalidomide as a nitric oxide synthase inhibitor and its structural development

Thalidomide has been found to exhibit weak nitric oxide synthase (NOS)-inhibitory activity. Structural development studies of thalidomide showed that some N-2,6-dimethylphenylhomophthalimide analogs possess NOS-inhibiting activity.     

A Novel Conversion of 2, 4‐Diaryl‐2, 3‐dihydro‐1 H‐1, 5‐benzodiazepines into 2, 4‐Diaryl‐3 H‐1, 5‐benzodiazepines

A novel conversion of 2, 4‐diaryl‐2, 3‐dihydro‐1 H‐1, 5‐benzodiazepins into 2, 4‐diaryl‐3 H‐1, 5‐benzodiazepines by the reaction with m‐chloroperbenzoic acid (MCPBA) was reported.     

Syntheses of new conformationally constrained S‐[2‐[(1‐iminoethyl)amino] ethyl]homocysteine derivatives as potential nitric oxide synthase inhibitors

The efficient syntheses of two new types of conformationally constrained S‐[2‐[(1‐iminoethyl)amino]ethyl]homocysteine derivatives, 1‐amino‐3‐[2[(1‐iminoethyl)amino]ethylthio]cyclobutane carboxylic Acid ( 5 ) and (4S)‐4‐[[2‐[(1‐Iminoethyl)amino]ethyl]thio]‐L‐proline ( 6 ), are reported. These molecules represent the first attempts to probe conformational constraint near the α‐amino acid moiety of known homocysteine‐based inhibitors of nitric oxide synthase. Targets 5 and 6 were evaluated as potential inhibitors of the three human isoforms of nitric oxide synthase. © 2002 John Wiley & Sons, Inc. Heteroatom Chem 13:77–83, 2002; DOI 10.1002/hc.1109     

Preparation of 2‐amino‐5‐methyl‐7H‐1,3,4‐thiadiazolo[3,2‐α]pyrimidin‐7‐ones

2‐Amino substituted 7H‐1,3,4‐thiadiazolo[3,2‐α]pyrimidin‐7‐ones 11a‐e were prepared by the reaction of 2‐bromo‐5‐amino‐1,3,4‐thiadiazole ( 1b ) and diketene ( 8 ), subsequent cyclocondensation ( 9b → 3b ) and displacement of the bromo substituents by the reaction with primary or secondary amines ( 3b → 11a‐e ). The hydrogen atom 6‐H in the heterobicycle 3b is replaced by a Cl or Br atom in the transformation of 3b → 14a,b. The 2‐bromo‐6‐chloro compound 14a reacts chemoselectively in the 2‐position with dimethylamine ( 14a → 15 ). The structure elucidations are based on one‐ and two‐dimensional NMR techniques including a heteronuclear NOE measurement.